SciDev and Iluka have agreed to a three year sales contract for Iluka’s flagship Jacinth Ambrosia site for its MaxiFlox® chemistry.
Revenue to SciDev is expected to be AUD $8M – AUD $12M over the duration of the contract for supply of the MaxiFlox® chemistry.
The contract follows a comprehensive period of evaluation of SciDev’s technology on site by the SciDev technical team in parallel with the Company’s OptiFlox® technology.
“This agreement is further validation of the commercial utility of our MaxiFlox® chemistry in the mine tailings space. Just as importantly, it highlights the calibre of the SciDev team in executing the technical and commercial evaluations over an extended period with a tier one Australian mining company”.
This transaction demonstrates that the SciDev team is able to deliver effective and bespoke solutions for tier-1 customers. Furthermore, this transaction represents a significant uplift in annual revenues from previous financial years which were ~A$2.2m in 2017/2018 and ~$2.9m in 2018/2019.
Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
